9:45 am Market Update: The market gained strength amid mixed global cues after the US Federal Reserve announced its first interest rate hike of the year and sees 2 more rate hikes in 2018.

The 30-share BSE Sensex was up 138.34 points at 33,274.52 and the 50-share NSE Nifty rose 49.40 points to 10,204.70.

About two shares advanced for every share falling on the BSE while all sectoral indices were in the green barring PSU Bank.

9:38 am Buzzing: Genus Power Infrastructures share price gained 3 percent on bagging an order for supply, installation, shifting & commissioning of 30,000 3Q meters, LT CT & HT meters with accessories including generation of first bill cycle & other incidental services.

9:34 am Order Win: IRB Infrastructure informed exchanges that the company has emerged as a preferred bidder for the project of six laning of Hapur bypass to Moradabad section including Hapur bypass from Km 50.000 to Km 148.277 of NH 24 in Uttar Pradesh on DBFOT basis under NHDP Phase V project.

9:30 am Buzzing: Shares of Sun Pharmaceutical Industries gained as much as 3.4 percent in morning as it has received USFDA approval for its psoriasis drug Ilumya.

Ilumya generically called as tildrakizumab-asmn falls in the category of specialty drugs – medications that treat complex or rare diseases such as cancer, autoimmune disorders, skin conditions among others.

Ilumya is used for the treatment of the most common plaque psoriasis – a chronic immune disease that appears on the skin.

Abhay Gandhi, President and Chief Executive Officer, North America, Sun Pharma said, “With the approval of ILUMY and our long-standing commitment in dermatology, we are focused on making a difference for people living with moderate-to-severe plaque psoriasis.”

9:25 am Gainers & Losers: Reliance Industries, L&T, Tata Motors, Vedanta, ONGC, Bharti Infratel, Eicher Motors, Sun Pharma and ITC gained up to 2 percent.

source: moneycontrol.com